News
Stay up to date on the latest crypto trends with our expert, in-depth coverage.

US Dollar Index holds above 99.00 as US-Iran talks stir uncertainty
101 finance·2026/03/25 04:36
Spanish Police Arrest Suspect in Kidnapping of Ledger Co-Founder David Balland
Cryptotale·2026/03/25 04:09

RBA's Jones: Beyond Acacia—What Lies Ahead for Innovation in the Financial System?
101 finance·2026/03/25 02:42
Pound Sterling bulls seem hesitant ahead of UK CPI; GBP/USD capped near 200-day SMA
101 finance·2026/03/25 02:33
SNB is now more prepared to step into the foreign exchange market, according to the chairman
101 finance·2026/03/25 02:24
Robinhood boosts buyback to $1.5B amid stock slide
Grafa·2026/03/25 01:51

BlackRock CEO Projects $500M Annual Crypto Revenue Within Five Years
Coincu·2026/03/25 01:31
Flash
21:14
Data released by Westpac Bank shows that New Zealand's Consumer Confidence Index fell to 80.4 in the second quarter, marking the lowest level in three years.The decline in the index also reflects that local residents remain cautious about the current economic environment and expectations regarding household income and expenditures. The recovery of consumer confidence will likely continue to depend on multiple fundamental factors such as a stable job market and easing inflation.
20:57
US Dollar Index Falls 0.09% on 16th The US Dollar Index fell 0.09% on the 16th, closing at 99.540 in the foreign exchange market.
20:48
According to a document submitted to the U.S. Securities and Exchange Commission, an agreement between Arvinas Holding Company LLC and Pfizer indicates that both parties are eligible for milestone payments totaling up to 320 millions USD, along with a tiered royalty structure.The document further clarifies the conditions and specific terms that trigger payment. Milestone payments will be distributed in phases based on the progress of R&D in the collaborative project, regulatory approvals, and commercialization outcomes at different stages. Tiered royalties mean that as product sales reach different thresholds, the rates will be adjusted accordingly, providing both parties with a more flexible revenue-sharing mechanism. This financial arrangement highlights both parties' confidence in the project's prospects and reflects the risk-sharing and profit-sharing models commonly seen in the biopharmaceutical industry. Although the details of the agreement have not been fully disclosed, the total potential revenue of up to $320 million undoubtedly injects strong financial momentum into the subsequent development of the project.
News